National Guideline Clearinghouse | Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2–negative (or unknown) advanced breast cancer: American Society of Clinical Oncology clinical practice guideline.
American Society of Clinical Oncology
Guideline Title
Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2–negative (or unknown) advanced breast cancer: American Society of Clinical Oncology clinical practice guideline.
Bibliographic Source(s)
Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, Gralow J, Hortobagyi GN, Moy B, Yee D, Brundage SB, Danso MA, Wilcox M, Smith IE. Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Oct 10;32(29):3307-29. [96 references] PubMed |
Guideline Status
This is the current release of the guideline.
This guideline meets NGC's 2013 (revised) inclusion criteria.
.-.-.-.
Chemotherapy and targeted therapy for women with human epidermal gr... - PubMed - NCBI
J Clin Oncol. 2014 Oct 10;32(29):3307-29. doi: 10.1200/JCO.2014.56.7479. Epub 2014 Sep 2.
Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Partridge AH1, Rumble RB1, Carey LA1, Come SE1, Davidson NE1, Di Leo A1, Gralow J1, Hortobagyi GN1, Moy B1, Yee D1, Brundage SB1, Danso MA1, Wilcox M1, Smith IE1.
Abstract
PURPOSE:
METHODS:
RESULTS:
RECOMMENDATIONS:
© 2014 by American Society of Clinical Oncology.
- PMID:
- 25185096
- [PubMed - indexed for MEDLINE]
No hay comentarios:
Publicar un comentario